The FDA has approved CSL Limited's H1N1 vaccine, already on the market for adults, for children 6 months and older. The expanded approval also included the Australian company's seasonal flu shots.
Published in Brief:
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||